• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

Article

Imiquimod Benefits Kids Off-Label

Bal Harbour, Fla. - The use of topically applied immune response modifier imiquimod (Aldara) goes beyond its FDA-approved application for the treatment of genital and perianal warts.

Related Videos
Related Content
“Open Sandwich” Moisturization Regimen Does Not Affect Bioactivity of Retinols and Retinoids
March 24th 2025

“Open Sandwich” Moisturization Regimen Does Not Affect Bioactivity of Retinols and Retinoids

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition
March 26th 2022

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

Q&A: How the PWRS Program and Inaugural Report is Empowering Women and Transforming Global Healthcare
March 21st 2025

Q&A: How the PWRS Program and Inaugural Report is Empowering Women and Transforming Global Healthcare

The Cutaneous Connection: Cosmetic Dermatology: Procedures and Practice
March 17th 2022

The Cutaneous Connection: Cosmetic Dermatology: Procedures and Practice

Novel Monopolar Radiofrequency Device is Effective and Safe for Facial Wrinkles
March 19th 2025

Novel Monopolar Radiofrequency Device is Effective and Safe for Facial Wrinkles

Analyzing Current Procedures for Periorbital Hyperpigmentation
March 18th 2025

Analyzing Current Procedures for Periorbital Hyperpigmentation

© 2025 MJH Life Sciences

All rights reserved.